What is the News?
The Ministry of Ayush has announced that it has taken steps to increase the production of AYUSH 64 across the country to treat mild to moderate cases of coronavirus infections.
- Ayush-64 is an Ayurvedic drug developed by the Central Council for Research in Ayurvedic Sciences(CCRAS), the apex body for research in Ayurveda under the Ministry of Ayush.
- The drug was originally developed in 1980 for the management of Malaria.
- However, this drug has now been repurposed for Covid-19 as its ingredients showed notable antiviral, immune-modulator, and antipyretic properties.
- The drug can be useful for the treatment of asymptomatic, mild, and moderate COVID-19 infection cases.
- The drug was found to significantly enhance the recovery in terms of disease symptoms and severity. It also has significant beneficial effects on general health, fatigue, anxiety, stress, appetite, general wellbeing, and sleep.
- Ayush-64 is a polyherbal formulation i.e. use of more than one herb. The development of the drug was in compliance with all regulatory requirements of pharmacopeial standards by the Central Council for Research in Ayurvedic Sciences (CCRAS)